No more reading glasses? early trial tests Light-Based corneal treatment

NCT ID NCT07208604

Not yet recruiting Symptom relief Sponsor: TECLens, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a non-invasive device that uses controlled UV light to reshape the cornea, potentially reducing the need for reading glasses in people with presbyopia. The study will enroll 25 adults aged 40 to 65 with healthy corneas. The main goal is to see if the treatment can safely and accurately correct refractive error within a small range of the target.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Quantitative refractive crosslinking (non-invasive UV light device)
What this could lead to: If successful, this could offer a non-surgical, one-time procedure to reduce or eliminate the need for reading glasses in people with presbyopia.
What could go wrong: This is a very early Phase I trial with only 25 participants, so safety and effectiveness are not yet proven. The procedure may not work for everyone, and there are risks like infection or corneal healing problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRESBYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperopia myopia presbyopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRESBYOPIA

Contacts and locations

Locations

Asian Eye Institute

Makati City, Philippines, Philippines

More trials for these conditions

Other studies related to the condition(s) this trial covers.